Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000972

Drug Information
NameNiflumic Acid
Synonyms2-(alpha,alpha,alpha-Trifluoro-m-toluidino)nicotinic acid; HMS1791F15; Nifluminic acid; HMS500N19; NCGC00023636-07; Spectrum4_000043; 2-(3-Trifluoromethyl-phenylamino)-nicotinic acid; AB00052255; Prestwick0_000255; KBioGR_000113; Acid, Niflumic; SMR000058199; KBio2_002681; 3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-; SC 1332; Prestwick3_000255; KBio2_000113; LS-96639; C13H9F3N2O2; HMS1921D12; Niflugel (TN); Spectrum3_001485; Niflumic acid (INN); 5-22-13-00598 (Beilstein Handbook Reference); 2-(3-[Trifluoromethyl]anilino)nicotinic acid; Spectrum5_001216; 2-[(3-Trifluoromethylphenyl)amino]nicotinic Acid; IDI1_000277; AB1004097; 39690A; CHEMBL63323; CCRIS 5740; N 0630; Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino [French]; BSPBio_000070; BRD-K98763141-001-06-8; BRD-K98763141-001-04-3; Forenol; Niflumic acid [INN:DCF]; Acide niflumique [French]; NCGC00023636-08; UPSA Conseil Brand of Niflumic Acid; BRN 0489360; 2-(3-(Trifluoromethyl)-phenyl)aminonicotinic acid; Lopac0_000845; 2-(3-Trifluoromethylanilino)nicotinic Acid; Acidum niflumicum; AC1L1IA4; HMS2090D19; D08275; Donalgin; KBio2_005249; NCGC00015724-06; 2-[3-(Trifluoromethyl)anilino]nicotinic acid; KBio3_000226; DivK1c_000277; NCGC00015724-03; Acido niflumico; Lopac-N-0630; Niflumate; Acide niflumique; 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID; Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino; SPBio_000928; Acido niflumico [Italian]; AKOS000519590; HMS1568D12; SPECTRUM1502015; EINECS 224-516-2; Niflam; NCGC00023636-03; 2-[(3-TRIFLUOROMETHYL)PHENYL]AMINO-3-PYRIDINE-CARBOXYLIC ACID; UPSA Brand 1 of Niflumic Acid; niflumic acid; CAS-4394-00-7; Spectrum_001353; NFL; NCGC00023636-04; BSPBio_003069; Bio2_000593; Niflugel; Landruma; UPSA Brand 2 of Niflumic Acid; 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid; CID4488; 3-Pyridinecarboxylic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-; Actol; KBio3_002569; KBioGR_000505; KBio3_000225; Nicotinic acid, 2-(alpha,alpha,alpha-trifluoro-m-toluidino)-; BAS 00821161; 1td7; KBio2_004401; Bio1_000603; CBiol_001828; Flunir; Acidum niflumicum [INN-Latin]; S00109; 2-(3-(Trifluoromethyl)anilino)nicotinic acid; HMS1989F15; NCGC00023636-09; Bio1_001092; Upsamedica Brand of Niflumic Acid; Prestwick1_000255; MLS001076327; NINDS_000277; UNII-4U5MP5IUD8; IDI1_033863; NCGC00015724-01; MolPort-000-140-647; 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid; NCGC00023636-05; HMS1361F15; NCGC00015724-13; N0630_SIGMA; Niflactol; KBio2_001833; Spectrum2_000794; EU-0100845; BPBio1_000078; Bio2_000113; STK803109; 2-[alpha,alpha,alpha-trifluoro-m-toluidino]-nicotinic acid; KBioSS_001833; DB04552; BSPBio_001393; NCGC00015724-02; C13698; SPBio_002289; Acide niflumique [INN-French]; NCGC00023636-06; KBio2_006969; AC-2652; UP 83; 2-[3-(Trifluoromethyl)anilino]nicotinic acid; 2-(|A,|A,|A-Trifluoro-m-toluidino)nicotinic acid; Prestwick2_000255; Nifluril; Acido niflumico [INN-Spanish]; KBio1_000277; 4394-00-7; 2-[(3-Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid; KBioSS_000113; MLS000069713; D009544; Bio1_000114; Prestwick_890
IndicationRheumatoid arthritis
[ICD9: 714   ICD10: M05-M06]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6
-17-11/h1-7H,(H,17,18)(H,19,20)
InChIKeyJZFPYUNJRRFVQU-UHFFFAOYSA-N
Canonical SMILESC1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F    
Therapeutic ClassAntiinflammatory Agents
CAS NumberCAS 4394-00-7
FormulaC13H9F3N2O2
PubChem Compound IDCID 4488.
PubChem Substance IDSID 163236.
SuperDrug ATC IDM01AX02; M02AA17
SuperDrug CAS ID004394007;
TargetCOX-2Inhibitor[2]
Ref 1Drug information of Niflumic Acid, 2008 To Reference
Ref 2Rat ovulation, implantation and decidualization are severely compromised by COX-2 inhibitors. Front Biosci. 2007 May 1;12:3333-42. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543